Source: Pixabay

Barrick Mining: Undergoing Strategic Restructuring

Barrick Mining is in the spotlight in the summer of 2026. While the gold price is trading above USD 4,000 per ounce, boosting the sector, an increasing number of analysts are revising their price targets downward. With its recent 9.9% strategic stake in the explorer Kingfisher Metals, Barrick has secured an option on the HWY-37 project in British Columbia’s promising Golden Triangle for approximately CAD 20.9 million. The transaction, which still requires approval from the securities regulator, could increase Barrick’s stake to 14.1% if the warrants are fully exercised. The funds are to be allocated primarily to the exploration and development of the project. The market reaction was positive, indicating confidence in this strategic move.

The most recent quarterly results painted a mixed picture. While Barrick significantly exceeded earnings per share expectations at USD 0.98, it fell short of the consensus estimate for revenue. Nevertheless, impressive year-over-year revenue growth of 66.7% and gold production above the company’s own forecast represent positive fundamentals. Downward revisions by analysts, including those from JPMorgan and the Royal Bank of Canada, cloud the picture, but the average price target of around USD 53 remains above the current level of USD 36.37.

The gold price remains the key driver of the share price. Trading above the psychological threshold of USD 4,000 supports producers’ margin expectations. However, geopolitical tensions and the prospect of a higher interest rate environment in the longer term are weighing on the sector. The upcoming quarterly results on August 10 will provide insight into operational performance and cost control. The lowered analyst estimates and short interest of around 1% in mid-June point to cautious market expectations, which leave room for upward movement in the event of positive surprises.

Lahontan Gold: On Track for Production in Nevada

Lahontan Gold is steadily advancing its Santa Fe project in Nevada. With fresh capital and a well-thought-out strategy, a potential start of production in 2027 is within reach. The company has achieved key milestones in recent months. The updated mineral resource estimate is imminent, followed by a revised preliminary economic assessment, which is expected by the end of August. The permitting process for mining operations is proceeding according to plan. Groundwater studies show that the planned open-pit mine will not impact the water table. The geochemical characterization of the waste rock is in full swing. With approval of the mine plan in the fourth quarter and a six-month construction phase, production could begin next year.

The 2026 drilling program is yielding promising results. In particular, the discovery of “Slab West,” a previously unrecognized gold zone west of the existing resource, underscores the exploration potential. With 87 completed drill holes and over 7,700 m drilled this year, the company is actively advancing its project. The historic heap leach pads are also being tested for remaining gold and silver, at very low development costs. The proximity to existing infrastructure and year-round operability at Nevada’s Walker Lane Trend offer clear competitive advantages.

The latest oversubscribed financing round of CAD 13.9 million, the early exercise of warrants, and cash reserves of approximately CAD 19.5 million secure funding through 2027. The West Santa Fe satellite project is located just 13 km away and exhibits oxidized mineralization at surface. This is ideal for low-cost open-pit mining. The cyanide leachability of gold and silver has been confirmed. The gold recovery rate was 81%, and the silver recovery rate was 60%. With an experienced management team that relies on contract mining rather than expensive in-house equipment, Lahontan is positioning itself for an efficient return to gold production. The share is currently trading at around CAD 0.38.

Newmont: Ahead of Quarterly Results

Newmont achieved a historic high in the first quarter with USD 3.1 billion in free cash flow and 1.3 million ounces of gold production. The company streamlined its balance sheet, sold several smaller mines, and focused on its most profitable Tier 1 assets in North America and Australia. With USD 8.8 billion in cash and net liquidity of USD 3.7 billion, the company is in a solid position. Shareholders benefited in the first half of the year from share buybacks totaling USD 2.4 billion and an annual dividend payout of approximately USD 1.1 billion.

The current year presents operational challenges. Expected production of 5.26 million ounces is below the previous year’s level. The decline results from planned mining sequences at sites such as Penasquito and Cadia. All-in sustaining costs are rising to approximately USD 1,680 per ounce. The gold price has corrected by about 25% since its record high, which is weighing on the share price. At the same time, the Red Chris Block Cave project in British Columbia is nearing an investment decision. The recently granted permits and the CAD 500 million financing commitment from the Canadian government could make this step possible as early as the second half of the year.

TD Cowen’s upgrade to “Buy” with a price target of USD 127 underscores the shift in sentiment. The analyst points to the 13% discount to the mine’s intrinsic value—a level that has rarely persisted historically. Added to this is the potential for further share buybacks this year, supported by strong liquidity. Although the dividend yield lags behind Barrick’s, investors betting on a production boost starting in 2027 and the copper outlook for Red Chris will find a compelling combination of value and growth. The Q2 results on July 23 will show whether the conservative forecast leaves room for surprises. The stock is currently trading at around USD 92.49.


The gold price above USD 4,000 and ongoing central bank purchases provide the sector with solid fundamental support. Barrick Mining is delivering strong operating results but is struggling with lowered analyst expectations. Lahontan Gold is determinedly pushing forward with its Nevada project and could begin production in 2027. Newmont impresses with strong liquidity and share buybacks, but faces declining production.


Conflict of interest

Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as “Relevant Persons”) currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a “Transaction”). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
In this respect, there is a concrete conflict of interest in the reporting on the companies.

In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is also a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

Risk notice

Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.

More From The Market Online

A Renewed Flare-Up of the Iran Conflict Fuels the Oil Industry: BP, Zefiro Methane, and Shell

The renewed escalation in the Middle East is having an immediate ripple effect on the oil and gas markets. Even the mere possibility of…

Another Setback for Rheinmetall? DroneShield Sounds the Alarm as Volatus Aerospace Pushes Ahead

Is the next German-French defence project headed for failure? In an interview with Welt am Sonntag, Rheinmetall CEO Armin Papperger warns of a possible…

These Are the Leaders in a League of Their Own! Despite price surges at Almonty, Micron, and Aixtron, Is There More Upside Ahead?

Over the past 12 months, stocks in the AI, commodities, and defence sectors have, on the whole, been investor favourites. Price surges were increasingly…

Panic in the Multi-Billion-Dollar Market: Novo Nordisk and Halozyme Therapeutics Face Headwinds—BioNxt Solutions Nears a Turning Point

The global pharmaceutical market is worth hundreds of billions of dollars. Yet one of the industry's most surprising realities is that success increasingly depends…